ESTEVE to acquire Regis Technologies.

ESTEVE, a pharmaceutical company, agreed to acquire Regis Technologies, a contract development and manufacturing organization. Financial terms were not disclosed. "We are proud to announce that we are increasing our team, and our CDMO solutions for pharmaceutical innovators: this acquisition is adding capabilities, as well as development and manufacturing capacity, while increasing the team of ESTEVE's CDMO business with around 70 skilled people", Joan Petit, ESTEVE Chief Industrial Operations Officer.